Following The Money: Institution’s Growing Stake In GSK Plc ADR (NYSE: GSK)
GSK Plc ADR (GSK) concluded trading on Thursday at a closing price of $36.96, with 6.24 million shares of worth about $230.7 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.98% during that period and on February 20, 2025 the price saw a […]
Analyst Expect Big Moves From GSK Plc ADR (NYSE: GSK)
Currently, there are 2.04B common shares owned by the public and among those 2.04B shares have been available to trade. The company’s stock has a 5-day price change of 3.53% and -1.61% over the past three months. GSK shares are trading 6.65% year to date (YTD), with the 12-month market performance down to -13.75% lower. […]
GSK Plc ADR (NYSE: GSK) Is Getting Increasingly Hard To Ignore
Currently, there are 2.04B common shares owned by the public and among those 2.04B shares have been available to trade. The company’s stock has a 5-day price change of -0.74% and -5.22% over the past three months. GSK shares are trading 3.02% year to date (YTD), with the 12-month market performance down to -14.25% lower. […]
Set Your Sights On GSK Plc ADR (NYSE: GSK)’S Upside Potential
GSK Plc ADR (GSK) concluded trading on Wednesday at a closing price of $35.06, with 6.06 million shares of worth about $212.35 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.37% during that period and on January 29, 2025 the price saw a […]
Set Your Sights On GSK Plc ADR (NYSE: GSK)’S Upside Potential
GSK Plc ADR (GSK) concluded trading on Thursday at a closing price of $34.05, with 3.74 million shares of worth about $127.25 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -12.33% during that period and on January 23, 2025 the price saw a […]
GSK Plc ADR (NYSE: GSK): Stock That Needs Special Handling
Currently, there are 2.04B common shares owned by the public and among those 2.04B shares have been available to trade. The company’s stock has a 5-day price change of -5.54% and -17.38% over the past three months. GSK shares are trading -5.14% year to date (YTD), with the 12-month market performance down to -19.07% lower. […]
GSK Plc ADR (NYSE: GSK) Stock In Prove Me State
GSK Plc ADR (GSK) concluded trading on Thursady at a closing price of $42.16, with 4.74 million shares of worth about $199.97 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 21.78% during that period and on Thursady the price saw a gain of […]
Why Should You Put GSK Plc ADR (NYSE: GSK) On Your Portfolio?
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
These Numbers Could Change Investor Views For GSK Plc ADR (NYSE: GSK)
Currently, there are 2.03B common shares owned by the public and among those 2.03B shares have been available to trade. Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, […]
GSK Plc ADR (GSK): Insights At A Glance
GSK Plc ADR (GSK) concluded trading on Wednesday at a closing price of $39.44, with 7.5 million shares of worth about $295.84 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 12.91% during that period and on Wednesday, January 31 the price saw a […]
